Literature DB >> 8327513

Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen.

J M Rini1, R L Stanfield, E A Stura, P A Salinas, A T Profy, I A Wilson.   

Abstract

The crystal structure of the Fab fragment of a human immunodeficiency virus type 1 (HIV-1) neutralizing monoclonal antibody Fab has been determined at 2.8 A resolution in complex with a linear 16-residue peptide from the third hypervariable region (V3) of gp120. The first 9 residues of the peptide are ordered in the electron density maps, and their conformation is in partial agreement with the beta-strand-type II beta-turn structure predicted for this portion of the V3 loop. Notably, several of the peptide residues that are well conserved among different HIV-1 isolates contact a nonpolar 25-A-long groove in the antibody-combining site. The largely extended structure of the peptide differs from the beta-turns seen as the primary determinants in other published anti-peptide Fab structures. Analysis of the specific Fab-peptide interactions only partially explains the MN isolate specificity shown by this antibody.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8327513      PMCID: PMC46921          DOI: 10.1073/pnas.90.13.6325

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120.

Authors:  E A Stura; R L Stanfield; G G Fieser; S Silver; M Roguska; L M Hincapie; H K Simmerman; A T Profy; I A Wilson
Journal:  Proteins       Date:  1992-12

2.  Structural evidence for induced fit as a mechanism for antibody-antigen recognition.

Authors:  J M Rini; U Schulze-Gahmen; I A Wilson
Journal:  Science       Date:  1992-02-21       Impact factor: 47.728

Review 3.  Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development.

Authors:  J Goudsmit; N K Back; P L Nara
Journal:  FASEB J       Date:  1991-07       Impact factor: 5.191

Review 4.  X-ray crystallographic analysis of free and antigen-complexed Fab fragments to investigate structural basis of immune recognition.

Authors:  I A Wilson; J M Rini; D H Fremont; G G Fieser; E A Stura
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 5.  Antibody-antigen complexes.

Authors:  D R Davies; E A Padlan; S Sheriff
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

6.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

7.  Side-chain torsional potentials: effect of dipeptide, protein, and solvent environment.

Authors:  B R Gelin; M Karplus
Journal:  Biochemistry       Date:  1979-04-03       Impact factor: 3.162

8.  Three-dimensional structure of an angiotensin II-Fab complex at 3 A: hormone recognition by an anti-idiotypic antibody.

Authors:  K C Garcia; P M Ronco; P J Verroust; A T Brünger; L M Amzel
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

9.  Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

Authors:  J R Rusche; K Javaherian; C McDanal; J Petro; D L Lynn; R Grimaila; A Langlois; R C Gallo; L O Arthur; P J Fischinger
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

10.  Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.

Authors:  E A Emini; W A Schleif; J H Nunberg; A J Conley; Y Eda; S Tokiyoshi; S D Putney; S Matsushita; K E Cobb; C M Jett
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

View more
  39 in total

1.  Backbone and C beta assignments of the anti-gp120 antibody Fv fragment complexed with an antigenic peptide.

Authors:  V Tugarinov; R Levy; A Dahan-Schokoroy; J Anglister
Journal:  J Biomol NMR       Date:  1999-02       Impact factor: 2.835

2.  Elbow flexibility and ligand-induced domain rearrangements in antibody Fab NC6.8: large effects of a small hapten.

Authors:  C A Sotriffer; B M Rode; J M Varga; K R Liedl
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

3.  Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design.

Authors:  Ralph Pantophlet; Ian A Wilson; Dennis R Burton
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody.

Authors:  Ki Joon Cho; Bert Schepens; Kristof Moonens; Lei Deng; Walter Fiers; Han Remaut; Xavier Saelens
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

5.  Dynamic domains and geometrical properties of HIV-1 gp120 during conformational changes induced by CD4 binding.

Authors:  Shu-Qun Liu; Shi-Xi Liu; Yun-Xin Fu
Journal:  J Mol Model       Date:  2006-11-28       Impact factor: 1.810

6.  Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization.

Authors:  Christian H Bell; Ralph Pantophlet; André Schiefner; Lisa A Cavacini; Robyn L Stanfield; Dennis R Burton; Ian A Wilson
Journal:  J Mol Biol       Date:  2007-11-13       Impact factor: 5.469

7.  Structure determination of an anti-HIV-1 Fab 447-52D-peptide complex from an epitaxially twinned data set.

Authors:  Amandeep K Dhillon; Robyn L Stanfield; Miroslaw K Gorny; Constance Williams; Susan Zolla-Pazner; Ian A Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-06-18

8.  Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses.

Authors:  Gwo-Yu Chuang; Yen-Ting Lai; Jeffrey C Boyington; Cheng Cheng; Hui Geng; Sandeep Narpala; Reda Rawi; Stephen D Schmidt; Yaroslav Tsybovsky; Raffaello Verardi; Kai Xu; Yongping Yang; Baoshan Zhang; Michael Chambers; Anita Changela; Angela R Corrigan; Rui Kong; Adam S Olia; Li Ou; Edward K Sarfo; Shuishu Wang; Winston Wu; Nicole A Doria-Rose; Adrian B McDermott; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

9.  The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor.

Authors:  Emmanuel G Cormier; Tatjana Dragic
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  The tyrosine corner: a feature of most Greek key beta-barrel proteins.

Authors:  J M Hemmingsen; K M Gernert; J S Richardson; D C Richardson
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.